Milagros C Romay1, Camilo Toro2, M Luisa Iruela-Arispe1,3. 1. Department of Molecular, Cell and Developmental Biology, University of California, Los Angeles, California. 2. Undiagnosed Diseases Program, National Institutes of Health, Bethesda, Maryland. 3. Molecular Biology Institute, University of California, Los Angeles, California, USA.
Abstract
PURPOSE OF REVIEW: Microvascular ischemic disease of the brain is a common cause of cognitive impairment and dementia, particularly in the context of preexisting cardiovascular risk factors and aging. This review summarizes our current understanding of the emerging molecular themes that underlie progressive and irreparable vascular disease leading to neuronal tissue injury and dementia. RECENT FINDINGS: Cardiometabolic risk factors including diabetes and hypertension are known to contribute to vascular disease. Currently, the impact of these risk factors on the integrity and function of the brain vasculature has been target of intense investigation. Molecularly, the consequences associated with these risk factors indicate that reactive oxygen species are strong contributors to cerebrovascular dysfunction and injury. In addition, genetic linkage analyses have identified penetrant monogenic causes of vascular dementia. Finally, recent reports begun to uncover a large number of polymorphisms associated with a higher risk for cerebrovascular disease. SUMMARY: A comprehensive picture of key risk factors and genetic predispositions that contribute to brain microvascular disease and result in vascular dementia is starting to emerge. Understanding their relationships and cross-interactions will significantly aid in the development of preventive and intervention strategies for this devastating condition.
PURPOSE OF REVIEW: Microvascular ischemic disease of the brain is a common cause of cognitive impairment and dementia, particularly in the context of preexisting cardiovascular risk factors and aging. This review summarizes our current understanding of the emerging molecular themes that underlie progressive and irreparable vascular disease leading to neuronal tissue injury and dementia. RECENT FINDINGS: Cardiometabolic risk factors including diabetes and hypertension are known to contribute to vascular disease. Currently, the impact of these risk factors on the integrity and function of the brain vasculature has been target of intense investigation. Molecularly, the consequences associated with these risk factors indicate that reactive oxygen species are strong contributors to cerebrovascular dysfunction and injury. In addition, genetic linkage analyses have identified penetrant monogenic causes of vascular dementia. Finally, recent reports begun to uncover a large number of polymorphisms associated with a higher risk for cerebrovascular disease. SUMMARY: A comprehensive picture of key risk factors and genetic predispositions that contribute to brain microvascular disease and result in vascular dementia is starting to emerge. Understanding their relationships and cross-interactions will significantly aid in the development of preventive and intervention strategies for this devastating condition.
Authors: Daniel Gackowski; Rafal Rozalski; Agnieszka Siomek; Tomasz Dziaman; Krzysztof Nicpon; Maciej Klimarczyk; Aleksander Araszkiewicz; Ryszard Olinski Journal: J Neurol Sci Date: 2007-09-20 Impact factor: 3.181
Authors: Deborah A Levine; Mohammed Kabeto; Kenneth M Langa; Lynda D Lisabeth; Mary A M Rogers; Andrzej T Galecki Journal: Stroke Date: 2015-05-21 Impact factor: 7.914
Authors: Martin Dichgans; Markus Holtmannspötter; Jürgen Herzog; Nils Peters; Michael Bergmann; Tarek A Yousry Journal: Stroke Date: 2002-01 Impact factor: 7.914
Authors: Anna Richards; Arn M J M van den Maagdenberg; Joanna C Jen; David Kavanagh; Paula Bertram; Dirk Spitzer; M Kathryn Liszewski; Maria-Louise Barilla-Labarca; Gisela M Terwindt; Yumi Kasai; Mike McLellan; Mark Gilbert Grand; Kaate R J Vanmolkot; Boukje de Vries; Jijun Wan; Michael J Kane; Hafsa Mamsa; Ruth Schäfer; Anine H Stam; Joost Haan; Paulus T V M de Jong; Caroline W Storimans; Mary J van Schooneveld; Jendo A Oosterhuis; Andreas Gschwendter; Martin Dichgans; Katya E Kotschet; Suzanne Hodgkinson; Todd A Hardy; Martin B Delatycki; Rula A Hajj-Ali; Parul H Kothari; Stanley F Nelson; Rune R Frants; Robert W Baloh; Michel D Ferrari; John P Atkinson Journal: Nat Genet Date: 2007-07-29 Impact factor: 38.330
Authors: Andrew N McCorkindale; Ellis Patrick; James A Duce; Boris Guennewig; Greg T Sutherland Journal: Front Aging Neurosci Date: 2022-04-25 Impact factor: 5.702
Authors: Laura Bianchi; Annalisa Altera; Virginia Barone; Denise Bonente; Tommaso Bacci; Elena De Benedetto; Luca Bini; Gian Marco Tosi; Federico Galvagni; Eugenio Bertelli Journal: Cells Date: 2022-08-15 Impact factor: 7.666